Featured Presenters

William T. Gibson

MD, PhD, FRCPC, FCCMG, Associate Professor, Department of Medical Genetics and Genomics, University of British Columbia; Senior Clinician Scientist, BC Children’s Hospital, Vancouver, BC, Canada

Severe Early-Onset Obesity: Genetic Causes and How to Diagnose Them

William Gibson MD PhD is a Senior Clinician Scientist at the BC Children’s Hospital Research Institute, affiliated with UBC. He is best known for his team’s discovery of the gene for Weaver syndrome in late 2011, and for their more recent discovery of EED-related overgrowth (Cohen-Gibson syndrome) in 2015-2016. Dr. Gibson did his MD at UWO, residency in Medical Genetics in Calgary and PhD at the University of Cambridge in the O’Rahilly lab.

As an Associate Professor in the Department of Medical Genetics at UBC, his team solves genetic disorders, with a focus on rare obesity and overgrowth syndromes. With funding from CIHR, his group is actively recruiting patients with severe, early-onset obesity, macrocephaly and/or tall stature. They are also actively recruiting patients with familial brain aneurysms (funded by the HSFC and the Brain Aneurysm Foundation). Dr. Gibson’s team welcomes contact and referrals from colleagues and trainees at every stage of their careers.


Dan Holmes

MD, Clinical Associate Professor, Pathology and Laboratory Medicine, University of British Columbia; Division Head, Clinical Chemistry, St. Paul’s Hospital, Vancouver, BC, Canada

Daniel Holmes did his undergraduate degree in Chemical Physics from the University of Toronto. He went to medical school at the University of British Columbia (UBC) where he also did his residency in Medical Biochemistry. He is a Clinical Professor of Pathology and Laboratory Medicine at UBC and Division Head of Clinical Chemistry at St. Paul’s Hospital in Vancouver. Interests include laboratory medicine statistics, clinical endocrinology with a focus on secondary hypertension, clinical lipidology and clinical mass spectrometry.


Mark Inman

MD, FRCPC, Pediatric Endocrinologist, Department of Pediatrics, Royal University Hospital; Clinical Assistant Professor, University of Saskatchewan, Saskatoon, SK, Canada

Finishing Fellowship: Tips for Transition to Practice

Mark Inman is a pediatric endocrinologist at the Royal University Hospital in Saskatoon and a clinical assistant professor at the University of Saskatchewan. He obtained his BSc at Acadia University in Wolfville NS (2005), MD at the University of Toronto in Toronto ON (2009), Pediatric Residency at Dalhousie University and IWK Health Center in Halifax NS (2013) and Pediatric Endocrine Fellowship at the University of Toronto and the Hospital for Sick Children (2015). He currently serves as the coordinator of the undergraduate medical education endocrine module at the University of Saskatchewan. His research interests include social determinants of health within pediatric diabetes care as well as quality improvement initiatives enhancing pediatric care.


Katie Larson Ode

MD, Clinical Associate Professor, Pediatric Endocrinology and Diabetes, University of Iowa Stead Family Children’s Hospital, Iowa City, IA, USA

Cystic Fibrosis Related Diabetes Mellitus (CFRD): A Common Rare Disease

Dr. Larson Ode obtained her MD from the University of Wisconsin and her residency in categorical pediatrics at Rainbow Babies and Children’s Hospital, Case Western Reserve University. She completed fellowship in Pediatric Endocrinology at the University of Minnesota, where she also completed a Masters in clinical research. Dr. Larson Ode is currently faculty at the University of Iowa. She has an active research program with ongoing NIH funding investigating the early pathogenesis of cystic fibrosis related diabetes mellitus (CFRD) in young children with CF. The University of Iowa has a rich environment of excellent basic science models for studying Cystic Fibrosis and CFRD; Dr. Larson Ode is a close collaborator with the CFRD teams which have developed two novel animal models (the CF ferret and CF pig), allowing, for the first time ever, animal models of CFRD where diabetes arises spontaneously in the context of the natural history of the disease. Dr. Larson Ode has also been recognized by the Cystic Fibrosis Foundation (CFF) as an emerging leader in CF endocrinology and has received grant support from the CFF for her clinical work in CFRD at the University of Iowa.


Dan Metzger

MD, Investigator, BC Children’s Hospital; Pediatric Endocrinologist, BC Children’s Hospital; Clinical Professor, Division of Endocrinology, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada

Endocrine Care of Trans Youth

Dr. Dan Metzger is a Clinical Professor of Pediatrics at the University of British Columbia, and a Pediatric Endocrinologist working on the Endocrinology & Diabetes Unit of BC Children’s Hospital. Dr. Metzger and his team, working with mental-health colleagues at BCCH and in the community as a “clinic without walls”, began seeing transgender kids in 1998. They have now seen nearly 400 kids, with one of the busiest clinics in Canada. In 2014, they published one of the first North American reports on the results of their experience caring for trans and gender-questioning children and youth.


Mark Palmert

MD, PhD, Associate Chair of Pediatrics (Ambulatory Care), Head, Division of Endocrinology, The Hospital for Sick Children, Toronto, ON, Canada

DEBATE: Be it resolved that growth hormone should be used in the treatment of children with idiopathic short stature (ISS) (Con Side)

Dr. Palmert is a Professor of Pediatrics and Physiology at the University of Toronto. Mark graduated from the Medical Scientist Training Program at Case Western Reserve University, Cleveland, Ohio, with a MD and PhD in 1992 and then completed his pediatrics and pediatric endocrinology training at the Children’s Hospital, Boston. Prior to moving to Toronto in 2007 to become Head of the Division of Endocrinology, Mark held staff positions in Boston and at the Rainbow Babies and Children’s Hospital in Cleveland. In 2017 Mark began a new role as Associate Chair of Pediatrics (Ambulatory Care) at SickKids.


Stacey Urbach

MD, MPH, FRCPC, Division of Endocrinology, The Hospital for Sick Chidren; Assistant Professor, Department of Paediatrics, University of Toronto, Toronto, ON, Canada

Endocrine Late Effects of Childhood Cancer Therapy: What We Know and What We Still Need To Learn

Dr. Stacey Urbach is a staff physician in the Division of Endocrinology at The Hospital for Sick Children in Toronto. She completed medical school at The University of Toronto and went on to do her pediatric residency and endocrine fellowship at SickKids. Dr. Urbach spent part of her fellowship training in Portland, Oregon where she completed a Master’s in Public Health. Her thesis examined the predictors of glucose control in children with Type 1 Diabetes. During her clinical training, Dr. Urbach had the opportunity to work with the members of the long term follow-up cancer care team at SickKids. Her area of interest lies is in the endocrine care of childhood cancer survivors and she has been instrumental in building the long term follow-up program which provides coordinated care for this vulnerable population.